Research programme: receptor for activated protein kinase C 1 antagonists - ProMIS Neurosciences
Alternative Names: RACK1 antagonists - ProMIS NeurosciencesLatest Information Update: 27 Apr 2023
At a glance
- Originator ProMIS Neurosciences
- Class Antibodies; Neuroprotectants
- Mechanism of Action Protein aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Amyotrophic lateral sclerosis; Huntington's disease